Inhibition of LINC00511 reduces It has ability to bind competitively to miR-185, which boosts STXBP4 production and enhances radiation responsiveness in BC. A prospective treatment approach for boosting the prognosis of BC is the LINC00511/miR-185/STXBP4 axis. The gene discussed is LINC00511; the disease is breast cancer.